Annulus Pharmaceuticals Private Limited
About Annulus Pharmaceuticals Private Limited
Data last updated:
Annulus Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 05 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2016PTC032682. Its GSTIN is 10AAOCA8476D1ZP (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Premchandra and Sadhu Sharan Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N/03 Revenue Colony Chitragupta Nagar Kankarbagh, Patna, Bihar, India – 800020.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.81 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹1.01 Lakh (net margin -9.4%) and EBITDA of -₹97,620 (EBITDA margin -9%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 15% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Annulus Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressN/03 Revenue Colony Chitragupta Nagar Kankarbagh, Patna, Bihar, India – 800020
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Annulus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Annulus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Annulus Pharmaceuticals Private Limited, buy the company report.
Financials of Annulus Pharmaceuticals Private Limited
FY 2025 filings availableAnnulus Pharmaceuticals Private Limited reported revenue of ₹10.81 Lakh (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 14% fall in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹97,620 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9% | ||||
| Net Profit Margin | -9.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Annulus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Annulus Pharmaceuticals Private Limited
Annulus Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Premchandra | Director | 16 Dec 2018 | 7 Years 10 Months | Current |
| Sadhu Sharan Singh | Director | 22 Apr 2019 | 7 Years 6 Months | Current |
| Mrigya Singh | Director | 22 Apr 2019 | 7 Years 6 Months | Current |
| Prakash Kumar Singh | Director | 05 Oct 2016 | 10 Years 0 Months | Current |
Peer comparison
Annulus Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zubin Pharmaceuticals Private Limited | ₹10.84 Lakh (FY 2018) | -6.0% | New Delhi, Delhi, India | |||
| Mendbrisk Pharmaceuticals Private Limited | ₹10.83 Lakh (FY 2021) | -10.0% | Nagpur, Maharashtra, India | |||
| Medizoid Pharmaceuticals Private Limited | ₹10.83 Lakh (FY 2024) | -17.0% | Nalagarh, Himachal Pradesh, India | |||
| Shree Karni Pharmaceuticals Private Limited | ₹10.82 Lakh (FY 2024) | Jodhpur, Rajasthan, India | ||||
| Annulus Pharmaceuticals Private Limitedthis company | ₹10.81 Lakh (FY 2025) | -₹1.01 Lakh | -9.4% | -14.0% | Patna, Bihar, India | |
| Medstream Pharmaceuticals (India) Private Limited | ₹10.76 Lakh (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Ak Pharmaceuticals Private Limited | ₹10.76 Lakh (FY 2025) | 22.0% | New Delhi, Delhi, India |
To see the full peer comparison of Annulus Pharmaceuticals Private Limited, buy the company report.
Auditor
Annulus Pharmaceuticals Private Limited is audited by Kumar Akash & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kumar Akash & Associates | FY 2017 | 021057C |
Shareholding
The shareholding of Annulus Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Annulus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Annulus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Annulus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Annulus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAOCA8476D1ZP | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Annulus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Annulus Pharmaceuticals Private Limited has 7 board changes on record since 2016: 4 appointments and 3 cessations. The latest: Mrigya Singh was appointed as Director on 22 Apr 2019.
Frequently asked questions
Annulus Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other services, within the business services industry. It was incorporated on 05 October 2016 (10+ years old) and is registered under CIN U74999BR2016PTC032682.
Annulus Pharmaceuticals has 4 current directors:
- Premchandra - Director
- Sadhu Sharan Singh - Director
- Mrigya Singh - Director
- Prakash Kumar Singh - Director
The latest financial statements of Annulus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Annulus Pharmaceuticals is 10AAOCA8476D1ZP, registered in Bihar.
The CIN (Corporate Identification Number) of Annulus Pharmaceuticals is U74999BR2016PTC032682. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Annulus Pharmaceuticals was incorporated on 05 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Annulus Pharmaceuticals by revenue are Zubin Pharmaceuticals Private Limited, Mendbrisk Pharmaceuticals Private Limited, Medizoid Pharmaceuticals Private Limited, Shree Karni Pharmaceuticals Private Limited, Medstream Pharmaceuticals (India) Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mrigya Singh was appointed as Director on 22 Apr 2019. Priyanka Singh ceased to be Director on 22 Apr 2019. Ravi Shankar Singh ceased to be Director on 22 Apr 2019. Annulus Pharmaceuticals has 7 board changes on record in total.
The registered office of Annulus Pharmaceuticals is at N03 Revenue Colony Chitragupta Nagar Kankarbagh, Patna, Bihar, India – 800020.
Annulus Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Annulus Pharmaceuticals is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.